bioXcelerate AI

Our mission is to enable our clients to unlock research-driven insights into drug discovery and clinical development. This is made possible through our team of highly skilled data scientists, who leverage their academic knowledge to apply cutting-edge statistics, machine learning, and software engineering.  At our core is the ability to tailor solutions that meet our clients' unique needs and computational infrastructure, all in the pursuit of speeding up the journey to critical healthcare insights.  By skillfully orchestrating our toolkits and expertise, we construct fully bespoke, end-to-end solutions that align precisely with our clients' objectives and empower them to make data-driven decisions with confidence and efficiency.

Content by bioXcelerate AI

Black, female scientist using a microscope for analysis in a healthcare lab
| 2 min read
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A 3D molecular visualization of antibody-like protein structures with attached yellow payloads floating against a dark, space-like background.
Evolving approaches to conjugation chemistry and linker–payload design are helping address persistent challenges in bioconjugate development.
Fluorescent-style illustration of spherical embryonic stem cells clustered together against a dark background.
Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes. 
3D illustration of ciliated cells, with cilia shown in blue.
Ultraprecise proteomic analysis reveals new insights into the molecular machinery of cilia.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue